Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

http://www.wikidata.org/entity/Q34752048

about

Cannabinoid CB1 receptor overactivity contributes to the pathogenesis of idiopathic pulmonary fibrosis.Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake.Endocannabinoid signaling at the periphery: 50 years after THC.The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity.Role of the endocannabinoid system in diabetes and diabetic complications.Cannabinoids and the Kidney: Effects in Health and Disease.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Increased Renal 2-Arachidonoylglycerol Level Is Associated with Improved Renal Function in a Mouse Model of Acute Kidney Injury.Pepcan-12 (RVD-hemopressin) is a CB2 receptor positive allosteric modulator constitutively secreted by adrenals and in liver upon tissue damage.Selective cannabinoid 2 receptor stimulation reduces tubular epithelial cell damage following renal ischemia-reperfusion injury.Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the Treatment of Diabetic Nephropathy.Obesity-Related CKD: When Kidneys Get the Munchies.Proximal Tubular Cannabinoid-1 Receptor Regulates Obesity-Induced CKD.Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type 2 Diabetes.Dual therapy targeting the endocannabinoid system prevents experimental diabetic nephropathy.Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis.Inhalation of Hydrogen Attenuates Progression of Chronic Heart Failure via Suppression of Oxidative Stress and P53 Related to Apoptosis Pathway in Rats

P2860

Q33579016-92C0890A-E49B-4785-B94C-295EEF435110 Q34557589-D2F6FB12-F5F2-449D-ABE0-1A99AB4BDC7B Q35572176-365AF72D-35F9-4B66-A76B-54C2591F7ED1 Q36506869-9E397C16-1E0F-4EA8-86DA-45794CB80F7E Q37085532-D5A87AA4-F7C7-4C3C-AC20-6BC0A57436A0 Q38651395-26760C7F-DB4D-412A-8573-2BA3CD48C43D Q38684679-2290FAF9-2C66-44DE-BECC-3180196FB6FF Q41150280-C0243166-0934-414D-9740-36C3F3556CBF Q41534560-8FB7DCB3-E7ED-49D8-AA73-228BD4F703BA Q47349963-CB139626-5745-4728-811E-10C0C5EFD71A Q47445806-E6002898-5E87-445B-A3CB-99CC88FB0D86 Q47671197-02D4D340-00FE-45EA-B4D3-0CA3903C1426 Q47874226-75B066B0-0FF3-4B37-A015-1C6547FF57C8 Q47985501-7A01D2D4-6942-45B3-8A1C-29662954109E Q50462161-AC0FBFAA-A9C7-4250-8EDE-F01F14D0A277 Q51067641-9A7CA8F0-214D-4DE9-AF48-856E523553CD Q52605264-88F619DC-5968-47DF-B520-DC022B1362CB Q57173959-56FCF20F-B078-4287-8787-3D9DF03C54BC

P2860

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

http://www.wikidata.org/entity/Q34752048

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@ast

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@en

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@nl

type

label

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@ast

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@en

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@nl

prefLabel

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@ast

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@en

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@nl

P1433

Q34752048-046BF941-CF8A-4AE5-88F6-B379ECD87BAD

P1476

Q34752048-61182874-1E6F-4D85-8DDD-D8BB2A3A41F2

P2093

Q34752048-1B48A982-1100-4418-9E9D-9F06A779F747

Q34752048-34D9FC12-6707-4E7C-A47F-408D92BC4CD6

Q34752048-6EC47190-31F5-4D4F-A311-8959DAD583F1

Q34752048-8CA3494A-8CCA-4A94-B4F5-14FCEE560745

Q34752048-D2306F31-B5A1-496C-AC30-FEA4D00382C9

Q34752048-F36D39BF-2EF2-4418-B99C-8A4734400717

Q34752048-F41DEAF7-5FF1-456A-BCEC-AAF09ACCDFDB

P2860

Q34752048-0000CEEF-B8C7-4098-8AC3-BA40943FBABA

Q34752048-0A3792F2-0CC3-4FB0-B3ED-EAF1A465B78E

Q34752048-1AD7A062-897F-4E32-BF6A-BAA923538621

Q34752048-1AEDD3A6-6459-4275-A713-D2225C146D7D

Q34752048-1F3DEB3A-D77C-4774-BBE3-6F016EDD55A1

Q34752048-212E4691-A714-4786-B22E-1455ED19501A

Q34752048-27DB3619-40F2-4AEE-B99C-807023D7AB6E

Q34752048-2986C1B4-BBB5-4E6B-AC86-894943570BF7

Q34752048-2D6DBA92-52D0-4281-97CB-7708C9A34FF3

Q34752048-316CE47A-96C2-4F29-85F2-E75F01B089E4

P304

Q34752048-752172A0-AE48-4BAE-BFBB-62D6D4BDA5A7

P31

Q34752048-DDAA4F41-CC2B-4B7E-95D8-60D2BE8BB129

P356

Q34752048-A649A26F-AE9B-44BD-9C01-76B97F2A8985

P407

Q34752048-5C2E3BF8-EC5C-421B-A716-680DF12E7FCF

P433

Q34752048-7E7E4AD1-D9DF-4708-BD6D-B204F5DBED3A

P478

Q34752048-158CF5F1-E2A0-448B-BFB0-3249D2DEE895

P50

Q34752048-10D059DD-CD29-48E6-8ABF-E8574AE3F99D

Q34752048-18FC26FF-FF14-4245-AD31-57B177151220

Q34752048-27BED708-0281-412F-979D-42BE5A522CB6

Q34752048-39046C4C-2DC3-4B1C-B46B-A99BAA135A2B

Q34752048-D781C683-E601-4439-A75E-95D6CC6A97CC

P577

Q34752048-44812644-8BD3-4994-922E-1F930DB961E3

P5875

Q34752048-9B3281BC-7D3C-448F-A8E5-D4128B747D9E

P698

Q34752048-20191175-933F-412D-A37A-FC96FA9ADD6E

P921

Q34752048-1CE4F255-783A-4453-ACFB-45AA0E31BDBE

Q34752048-AD9E81AA-FA14-463E-B277-D4148854E818

Q34752048-db91f85d-f514-4ad9-844a-ff9ba7c0b01c

P932

Q34752048-A7883AF2-317D-43DE-B252-8B3F595115DD

P356

PNAS.1419901111

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.

@en

P2093

Cynthia Ju

http://www.w3.org/2001/XMLSchema#string

George Kunos

http://www.w3.org/2001/XMLSchema#string

Gergő Szanda

http://www.w3.org/2001/XMLSchema#string

Grzegorz Godlewski

http://www.w3.org/2001/XMLSchema#string

Jie Liu

http://www.w3.org/2001/XMLSchema#string

Joseph Tam

http://www.w3.org/2001/XMLSchema#string

Ziyi Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol

Angiotensin II reduces cardiac AdipoR1 expression through AT1 receptor/ROS/ERK1/2/c-Myc pathway

Podocyte biology and pathogenesis of kidney disease

Activation of the Nlrp3 inflammasome in infiltrating macrophages by endocannabinoids mediates beta cell loss in type 2 diabetes.

Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.

CB1 antagonism exerts specific molecular effects on visceral and subcutaneous fat and reverses liver steatosis in diet-induced obese mice

Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoic acid acting via retinoic acid receptor-gamma.

Peripheral CB1 cannabinoid receptor blockade improves cardiometabolic risk in mouse models of obesity.

Role of angiotensin II in diabetic nephropathy.

Peripheral cannabinoid-1 receptor inverse agonism reduces obesity by reversing leptin resistance.

P304

E5420-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.1419901111

http://www.w3.org/2001/XMLSchema#string

P407

P433

50

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P50

Brian James Earley

P577

2014-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268926021

http://www.w3.org/2001/XMLSchema#string

P698

25422468

http://www.w3.org/2001/XMLSchema#string

P921

cannabinoid receptor

P932

4273328

http://www.w3.org/2001/XMLSchema#string